Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research on breast cancer discussed by scientists at Matsumoto Dental University
February 26th, 2009
According to recent research published in the Journal of Bone and Mineral Metabolism, "Osteoclasts are formed from the monocyte-macrophage lineage in response to receptor activator of nuclear factor kappa B ligand (RANKL) expressed by osteoblasts. Bone is the most common site of breast cancer metastasis, and osteoclasts play roles in the metastasis." "The taxane-derived compounds paclitaxel and docetaxel are used for the treatment of malignant diseases, including breast cancer. Here we explored the effects of docetaxel on osteoclastic bone resorption in mouse culture systems. Osteoclasts were formed within 6 days in cocultures of osteoblasts and bone marrow cells...
Source: Women's Health Weekly (2009-02-26)
|
